Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
-
Ocugen to Participate in Fireside Chat at Chardan’s 7th Annual Genetic Medicines Conference
-
Ocugen, Inc. to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
Ocugen, Inc. to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
Ocugen, Inc. (OCGN) PT Lowered to $4.50 at Chardan Capital Markets
-
Pre-Open Stock Movers 02/09: (KALV) (HTBX) (GLUU) Higher; (BRPA) (INFI) (OCGN) Lower (more...)
-
Chardan Capital Markets Downgrades Ocugen, Inc. (OCGN) to Neutral Following Run-Up
-
Ocugen to Participate in a Virtual Fireside Chat at the Chardan Genetic Medicines Conference
-
Pre-Open Movers 11/27 (AVX) (MDR) (TNXP) Higher; (ARAV) (GES) (DELL) Lower (more...)
-
Ocugen (OCGN) Ramps 20%+ on New Buy Rating
-
Chardan Capital Markets Starts Ocugen, Inc. (OCGN) at Buy
-
Ocugen Announces Completion of its Merger with Histogenics to Create Nasdaq-Listed Clinical-Stage Company Developing Novel Ocular Gene Therapies and Biotherapeutics
